Quick Answer
NICE Ltd. reported R&D Expense of $360.45 million for fiscal year 2025.
NICE Ltd. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $360.45M | -0.0% |
| 2024 | $360.61M | +11.7% |
| 2023 | $322.71M | +5.4% |
| 2022 | $306.07M | +12.9% |
| 2021 | $271.19M | +24.3% |
| 2020 | $218.18M | +12.6% |
| 2019 | $193.72M | +5.4% |
| 2018 | $183.83M | +1.5% |
| 2017 | $181.11M | +28.0% |
| 2016 | $141.53M | +10.2% |
| 2015 | $128.49M | +4.3% |
| 2014 | $123.14M | +6.7% |
| 2013 | $115.43M | -4.9% |
| 2012 | $121.39M | +11.2% |
| 2011 | $109.13M | +12.4% |
| 2010 | $97.08M | +25.5% |
| 2009 | $77.38M | -1.4% |
| 2008 | $78.44M | — |
- NICE Ltd. showed a decrease of -0.0% in R&D Expense compared to the prior fiscal year.
- Over the 2008–2025 period, NICE Ltd.’s r&d expense has grown by 359.5% (from $78.44 million to $360.45 million).
- The most recent figure is from NICE Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: